vs

Side-by-side financial comparison of Andersons, Inc. (ANDE) and CAMTEK LTD (CAMT). Click either name above to swap in a different company.

Andersons, Inc. is the larger business by last-quarter revenue ($329.5M vs $242.0M, roughly 1.4× CAMTEK LTD). CAMTEK LTD runs the higher net margin — 28.1% vs 20.5%, a 7.6% gap on every dollar of revenue.

The Andersons, Inc. is an American agribusiness established in 1947, that began as Andersons Truck Terminal (ATT) in the 1940s for the grain industry, headquartered in Maumee, Ohio. It is a diversified company rooted in agriculture that conducts business in the commodity merchandising, renewables, and plant nutrient sectors.

Camtek Ltd is a leading global developer and manufacturer of high-precision inspection and metrology systems for the semiconductor, printed circuit board, and advanced packaging industries. Its solutions support process control, defect detection, and yield optimization for clients across Asia, North America, and Europe.

ANDE vs CAMT — Head-to-Head

Bigger by revenue
ANDE
ANDE
1.4× larger
ANDE
$329.5M
$242.0M
CAMT
Higher net margin
CAMT
CAMT
7.6% more per $
CAMT
28.1%
20.5%
ANDE

Income Statement — Q4 FY2025 vs Q2 FY2025

Metric
ANDE
ANDE
CAMT
CAMT
Revenue
$329.5M
$242.0M
Net Profit
$67.4M
$68.0M
Gross Margin
70.3%
50.9%
Operating Margin
26.6%
26.7%
Net Margin
20.5%
28.1%
Revenue YoY
-2.4%
Net Profit YoY
49.6%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANDE
ANDE
CAMT
CAMT
Q4 25
$329.5M
Q3 25
$295.8M
Q2 25
$535.0M
$242.0M
Q1 25
$370.8M
Q4 24
$337.5M
Q3 24
$231.9M
Q2 24
$492.5M
$199.6M
Q1 24
$341.4M
Net Profit
ANDE
ANDE
CAMT
CAMT
Q4 25
$67.4M
Q3 25
$20.1M
Q2 25
$7.9M
$68.0M
Q1 25
$284.0K
Q4 24
$45.1M
Q3 24
$27.4M
Q2 24
$36.0M
$52.8M
Q1 24
$5.6M
Gross Margin
ANDE
ANDE
CAMT
CAMT
Q4 25
70.3%
Q3 25
57.8%
Q2 25
29.6%
50.9%
Q1 25
41.2%
Q4 24
63.1%
Q3 24
76.4%
Q2 24
35.6%
48.1%
Q1 24
37.6%
Operating Margin
ANDE
ANDE
CAMT
CAMT
Q4 25
26.6%
Q3 25
8.7%
Q2 25
4.6%
26.7%
Q1 25
0.9%
Q4 24
19.9%
Q3 24
26.8%
Q2 24
11.6%
23.6%
Q1 24
4.1%
Net Margin
ANDE
ANDE
CAMT
CAMT
Q4 25
20.5%
Q3 25
6.8%
Q2 25
1.5%
28.1%
Q1 25
0.1%
Q4 24
13.4%
Q3 24
11.8%
Q2 24
7.3%
26.4%
Q1 24
1.6%
EPS (diluted)
ANDE
ANDE
CAMT
CAMT
Q4 25
Q3 25
$0.59
Q2 25
$0.23
Q1 25
$0.01
Q4 24
$1.31
Q3 24
$0.80
Q2 24
$1.05
Q1 24
$0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANDE
ANDE
CAMT
CAMT
Cash + ST InvestmentsLiquidity on hand
$98.3M
$232.0M
Total DebtLower is stronger
$560.0M
Stockholders' EquityBook value
$1.2B
$626.5M
Total Assets
$3.7B
$974.7M
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANDE
ANDE
CAMT
CAMT
Q4 25
$98.3M
Q3 25
Q2 25
$232.0M
Q1 25
Q4 24
$561.8M
Q3 24
Q2 24
$109.8M
Q1 24
Total Debt
ANDE
ANDE
CAMT
CAMT
Q4 25
$560.0M
Q3 25
Q2 25
Q1 25
Q4 24
$608.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ANDE
ANDE
CAMT
CAMT
Q4 25
$1.2B
Q3 25
$1.2B
Q2 25
$1.4B
$626.5M
Q1 25
$1.4B
Q4 24
$1.4B
Q3 24
$1.3B
Q2 24
$1.3B
$475.4M
Q1 24
$1.3B
Total Assets
ANDE
ANDE
CAMT
CAMT
Q4 25
$3.7B
Q3 25
$3.3B
Q2 25
$3.4B
$974.7M
Q1 25
$3.8B
Q4 24
$4.1B
Q3 24
$3.4B
Q2 24
$3.3B
$796.2M
Q1 24
$3.3B
Debt / Equity
ANDE
ANDE
CAMT
CAMT
Q4 25
0.45×
Q3 25
Q2 25
Q1 25
Q4 24
0.45×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANDE
ANDE
CAMT
CAMT
Operating Cash FlowLast quarter
$-6.2M
$47.1M
Free Cash FlowOCF − Capex
$-77.1M
FCF MarginFCF / Revenue
-23.4%
Capex IntensityCapex / Revenue
21.5%
Cash ConversionOCF / Net Profit
-0.09×
0.69×
TTM Free Cash FlowTrailing 4 quarters
$-56.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANDE
ANDE
CAMT
CAMT
Q4 25
$-6.2M
Q3 25
$233.9M
Q2 25
$299.3M
$47.1M
Q1 25
$-350.0M
Q4 24
$268.8M
Q3 24
$-2.1M
Q2 24
$304.4M
$70.1M
Q1 24
$-239.6M
Free Cash Flow
ANDE
ANDE
CAMT
CAMT
Q4 25
$-77.1M
Q3 25
$167.0M
Q2 25
$250.5M
Q1 25
$-396.6M
Q4 24
$212.9M
Q3 24
$-40.0M
Q2 24
$275.8M
Q1 24
$-266.4M
FCF Margin
ANDE
ANDE
CAMT
CAMT
Q4 25
-23.4%
Q3 25
56.5%
Q2 25
46.8%
Q1 25
-106.9%
Q4 24
63.1%
Q3 24
-17.2%
Q2 24
56.0%
Q1 24
-78.0%
Capex Intensity
ANDE
ANDE
CAMT
CAMT
Q4 25
21.5%
Q3 25
22.6%
Q2 25
9.1%
Q1 25
12.6%
Q4 24
16.6%
Q3 24
16.3%
Q2 24
5.8%
Q1 24
7.8%
Cash Conversion
ANDE
ANDE
CAMT
CAMT
Q4 25
-0.09×
Q3 25
11.61×
Q2 25
38.10×
0.69×
Q1 25
-1232.46×
Q4 24
5.96×
Q3 24
-0.08×
Q2 24
8.46×
1.33×
Q1 24
-42.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ANDE
ANDE

Specialty And Primary Nutrients$137.1M42%
Premium Ingredients$66.1M20%
Segment Reporting Reconciling Item Other$63.2M19%
Other$63.1M19%

CAMT
CAMT

Segment breakdown not available.

Related Comparisons